Foetal Outcomes Sample Clauses

Foetal Outcomes. The overall foetal mortality rate was 7% (4/60). This comprised of 4 deaths; 2 deaths occurred in foetuses from patients with HELLP syndrome, whereas 2 occurred in patients with AFLP. Three of the four foetal deaths occurred in women with twin pregnancies. The first foetal death was in a 35 year old woman who was pregnant with twins, and presented at 30 weeks gestation with HELLP syndrome complicated by a sub-capsular haematoma. An emergency caesarean section was preformed but the second twin was still born. The subsequent two foetal deaths occurred in a 30 year old woman who presented with abdominal pain at 34 weeks gestation, was diagnosed with AFLP and went into spontaneous labour 36 hours after presentation. Unfortunately both her twins were still born. She subsequently developed grade IV encephalopathy, required intubation for airway protection, but recovered with supportive medical care. The final foetal death occurred in a 28 year old women who presented with nausea, vomiting and abdominal pain at 31 weeks gestation. She was diagnosed with HELLP syndrome, which was complicated by ischaemic hepatitis secondary to placental abruption. The baby was delivered vaginally, but was still born. The women developed ascites and renal failure but recovered with supportive medical care. Interestingly foetal death was not associated with the severity of the maternal liver disease, as guided by maternal platelet count, INR, bilirubin, AST, creatinine or the presence of encephalopathy. (Table 4.5.3) This is likely due to the rapid delivery of the fetus. (90% within 24 hours) Table 4.5.3: Severity of maternal liver disease at presentation and impact on foetal survival Foetal Death (n=4) Foetal Survival (n=56) Median age at presentation 30 (28-35) 30 (21-40) Week of gestation 31 (30-34) 35 (27-40) Number encephalopathic 1 6 99 (58-116) 55 (15-225) Platelet count (150-450 cells/µL) Creatinine (45-120 mg/dL) 247 (67-262) 152 (52-396) AST (10-50 IU/L) 975 (78-5041) 307 (16-775) Bilirubin (3-20 µmol/L) 53 (30-87) 63 (9-388) Lactate (<2 mg/dl) 2.0 (0.7-2.9) 2.0 (0.8-18.0) INR (0.9-1.2) 1.06 (1.03 – 1.58) 1.40 (0.84-4.3) * Statistical significant value for Foetal death vs. Foetal survival (p<0.05). Thirteen neonates required admission to the special care baby unit for supportive care and all were subsequently discharged, with no ongoing medical sequelae. Admission to the SCBU was associated with earlier maternal gestation (34 (27-36) vs. 36 (35-42)).
AutoNDA by SimpleDocs

Related to Foetal Outcomes

  • Geometric visibility The visibility of the illuminating surface, including its visibility in areas which do not appear to be illuminated in the direction of observation considered, shall be ensured within a divergent space defined by generating lines based on the perimeter of the illuminating surface and forming an angle of not less than 5° with the axis of reference of the headlamp. The origin of the angles of geometric visibility is the perimeter of the projection of the illuminating surface on a transverse plane tangent to the foremost part of the lens of the headlamp.

  • Excellent Above Average Satisfactory Needs Improvement Unsatisfactory 5 4 3 2 1 5. The instructor demonstrates knowledge of the subject matter.

  • Study Population ‌ Infants who underwent creation of an enterostomy receiving postoperative care and awaiting enterostomy closure: to be assessed for eligibility: n = 201 to be assigned to the study: n = 106 to be analysed: n = 106 Duration of intervention per patient of the intervention group: 6 weeks between enterostomy creation and enterostomy closure Follow-up per patient: 3 months, 6 months and 12 months post enterostomy closure, following enterostomy closure (12-month follow-up only applicable for patients that are recruited early enough to complete this follow-up within the 48 month of overall study duration).

  • Infectious Disease Where an employee produces documentary evidence that:

  • Infection Control Consistent with the Centers for Disease Control and Prevention Guideline for Infection Control in Health Care Personnel, and University Policy 3364-109-EH-603, the parties agree that all bargaining unit employees who come in contact with patients in the hospital or ambulatory care clinics will need to be vaccinated against influenza when flu season begins each fall. The influenza vaccine will be offered to all health care workers, including pregnant women, before the influenza season, unless otherwise medically contraindicated or it compromises sincerely held religious beliefs.

  • Supervisory Control and Data Acquisition (SCADA) Capability The wind plant shall provide SCADA capability to transmit data and receive instructions from the ISO and/or the Connecting Transmission Owner for the Transmission District to which the wind generating plant will be interconnected, as applicable, to protect system reliability. The Connecting Transmission Owner for the Transmission District to which the wind generating plant will be interconnected and the wind plant Developer shall determine what SCADA information is essential for the proposed wind plant, taking into account the size of the plant and its characteristics, location, and importance in maintaining generation resource adequacy and transmission system reliability in its area.

  • Infrastructure Vulnerability Scanning Supplier will scan its internal environments (e.g., servers, network devices, etc.) related to Deliverables monthly and external environments related to Deliverables weekly. Supplier will have a defined process to address any findings but will ensure that any high-risk vulnerabilities are addressed within 30 days.

  • Nepotism No employee shall be awarded a position where he/she is to be directly supervised by a member of his/her immediate family. “

  • Dangerous Goods, Special Wastes, Pesticides and Harmful Substances Where employees are required to work with or are exposed to any dangerous good, special waste, pesticide or harmful substance, the Employer shall ensure that the employees are adequately trained in the identification, safe handling, use, storage, and/or disposal of same.

  • Population The Population shall be defined as all Paid Claims during the 12-month period covered by the Claims Review.

Time is Money Join Law Insider Premium to draft better contracts faster.